Jose Antonio Bouzada

Mr. Jose Antonio Bouzada

Laboratorio Central de Veterinaria, Madrid, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
OBOLGA BASSY
OLGA BASSY
MAMarkus Antwerpen
Markus Antwerpen
MGMaria Victoria Ortega García
Maria Victoria Ortega García
MOMaría Jesús Ortega-Sánchez
María Jesús Ortega-Sánchez
JBJose Antonio Bouzada
Jose Antonio Bouzada
Gregor GrassGregor Grass
Gregor Grass
The geographical origin of a major present-day phylogenetic group (A branch WNA; A.Br.WNA) of American Bacillus anthracis is controversial. One hypothesis postulated that the anthrax pathogen reached North America via a then-existing land bridge from northeastern Asia thousands of years ago. A competing hypothesis suggested that B. anthracis was introduced to America a couple of hundred years ago, related to European colonization. The latter view is strongly supported by genomic analysis of a group of French B. anthracis isolates that are phylogenetically closely related to the North American strains of the A branch A.Br.WNA clade. In addition, three West African strains also belong to this relationship group. Recently, we have added a Spanish strain to these close relatives of the WNA lineage of American B. anthracis. Nevertheless, the diversity of Spanish B. anthracis remains largely unexplored, and phylogenetic links to European or American relatives are not well resolved. Here, we genome sequenced and characterized 29 new B. anthracis isolates (yielding 18 unique genotypes) from outbreaks in west central and central Spain in 2021. Applying comparative chromosomal analysis, we placed the chromosomes of these isolates within the established phylogeny of the A.Br.008/009 (A.Br.TEA) canonical SNP group. From this analysis, a new sub-clade, named A.Br.11/ESPc, emerged that constitutes a sister group of American A.Br.WNA.

15 July 2022 in Viruses
Verified
Journal Article
Open access
PDF file
MDManuel Durán-Ferrer
Manuel Durán-Ferrer
RVRuben Villalba
Ruben Villalba
PFPaloma Fernández-Pacheco
Paloma Fernández-Pacheco
CTCristina Tena-Tomás
Cristina Tena-Tomás
Miguel Angel Jimenez-ClaveroMiguel Angel Jimenez-Clavero
Miguel Angel Jimenez-Clavero
MAMontserrat Agüero
Montserrat Agüero
This study described the clinical, virological, and serological responses of immunologically naïve and vaccinated horses to African horse sickness virus (AHSV) serotype 9. Naïve horses developed a clinical picture resembling the cardiac form of African horse sickness. This was characterized by inappetence, reduced activity, and hyperthermia leading to lethargy and immobility–recumbency by days 9–10 post-infection, an end-point criteria for euthanasia. After challenge, unvaccinated horses were viremic from days 3 or 4 post-infection till euthanasia, as detected by serogroup-specific (GS) real time RT-PCR (rRT-PCR) and virus isolation. Virus isolation, antigen ELISA, and GS-rRT-PCR also demonstrated high sensitivity in the post-mortem detection of the pathogen. After infection, serogroup-specific VP7 antibodies were undetectable by blocking ELISA (b-ELISA) in 2 out of 3 unvaccinated horses during the course of the disease (9–10 dpi). Vaccinated horses did not show significant side effects post-vaccination and were largely asymptomatic after the AHSV-9 challenge. VP7-specific antibodies could not be detected by the b-ELISA until day 21 and day 30 post-inoculation, respectively. Virus neutralizing antibody titres were low or even undetectable for specific serotypes in the vaccinated horses. Virus isolation and GS-rRT-PCR detected the presence of AHSV vaccine strains genomes and infectious vaccine virus after vaccination and challenge. This study established an experimental infection model of AHSV-9 in horses and characterized the main clinical, virological, and immunological parameters in both immunologically naïve and vaccinated horses using standardized bio-assays.

23 April 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
RVRuben Villalba
Ruben Villalba
BDBernabé Diéguez-Roda
Bernabé Diéguez-Roda
LJLaura Jiménez-Guerrero
Laura Jiménez-Guerrero
MVMarta Valero-Lorenzo
Marta Valero-Lorenzo
MRM.José Ruano
M.José Ruano
MAMontserrat Agüero
Montserrat Agüero
Bluetongue (BT) is an infectious, non-contagious, arthropod-borne viral disease of ruminants, and has a severe impact on livestock. It is caused by Bluetongue virus (BTV), a double-stranded (ds) RNA virus with a segmented genome (10 segments), belonging to the Seoreoviridae family, Orbivirus genus. Over the last 25 years, Europe has suffered multiple incursions of different BTV serotypes with serious consequences, which have mainly been controlled thanks to vaccination. In the case of Spain, from 2000 to 2023, BTV serotypes 1, 2, 4 and 8 have caused epidemics, and, sporadically, BTV-1 and -4 were detected in the same area and period. In 2024, BTV serotypes 1, 3 and 8 circulated simultaneously in the southwest of the country, causing a severe clinical impact in sheep but also in cattle and a multitude of outbreaks. Additionally, despite vaccination, serotype 4 also circulated that year, especially in areas where the other serotypes were already circulating. Whole-genome sequencing and phylogenetic analyses allowed us to confirm that serotypes 1 and 4 were homologous to viruses circulating in the country since 2000s, while serotypes 3 and 8 were homologous to BTVs recently notified in neighboring countries. In this context, many BTV co-infections of two or more different serotypes were confirmed by serotype-specific RT-PCRs, both in farms and individual animals. An epidemic caused by four serotypes coinciding in space and time had never occurred before in Spain, being a challenge for the diagnosis and control of this disease. Moreover, it could have favored the appearance of reassortant viruses with an unknown virulence, posing an additional risk. The data presented here raise the question of whether the co-circulation of different BTV strains, an exceptional situation, could become the new normal in certain areas of Europe.

24 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
RVRuben Villalba
Ruben Villalba
BDBernabé Diéguez-Roda
Bernabé Diéguez-Roda
LJLaura Jiménez-Guerrero
Laura Jiménez-Guerrero
MVMarta Valero-Lorenzo
Marta Valero-Lorenzo
MRM.José Ruano
M.José Ruano
MAMontserrat Agüero
Montserrat Agüero
Bluetongue (BT) is an infectious, non-contagious, arthropod-borne viral diseases of ruminants, producing severe impacts in livestock. It is caused by Bluetongue virus (BTV), a double-stranded (ds) RNA virus with segmented genome (10 segments), belonging to Seoreoviridae family, Orbivirus genus. Over the last 25 years, Europe has suffered multiple incursions of different BTV serotypes with serious consequences, which have been controlled mainly thanks to vaccination. In the case of Spain, since 2000 to 2023, BTV serotypes 1, 2, 4 and 8 have caused epidemics, and sporadically BTV-1 and -4 were detected in the same area and period. In 2024, BTV serotypes 1, 3 and 8 circulated simultaneously in the southwest of the country, causing a severe clinical impact especially on sheep but also in cattle and a multitude of outbreaks. Additionally, despite vaccination, also circulated serotype 4 that year, especially in areas where the other serotypes were already circulating. Whole Genome Sequencing and phylogenetic analyses allowed us to confirm that serotypes 1 and 4 were homologous to viruses circulating in the country since 2000s, while serotypes 3 and 8 were homologous to BTV viruses recently notified in neighboring countries. In this context, many BTV co-infections of two or more different serotypes were confirmed by serotype specific RT-PCRs both in farms and individual animals. An epidemic caused by four serotypes coinciding in space and time had never occurred before in Spain, being a challenge for the diagnosis and control of this disease. Moreover, it could have favored the appearance of reassortant viruses with an unknown virulence, posing an additional risk. The data presented here raises the question of whether the co-circulation of different BTV strains, an exceptional situation, could become the new normal in certain areas of Europe.